Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Preparation and use of new TK inhibitors as antiangiogenic agents

Oct. 17, 2000

Interaction regulating apoptosis could impact cancer therapy development

Oct. 17, 2000

Boehringer Ingelheim synthesizes new series of tyrosine kinase inhibitors

Oct. 16, 2000

Strategic collaboration aims to develop new cancer immunotherapies

Oct. 16, 2000

Market launch for Trisenox, a new Rx for a severe form of leukemia

Oct. 16, 2000

Intensive PEG-L-asparaginase regimen improves remission rates in ALL

Oct. 16, 2000

Recent patent covers new approach to managing certain side effects of cancer therapy

Oct. 13, 2000

Series of patents issued to Merck for new protein prenyltransferase inhibitors

Oct. 13, 2000

Engineered prostate cancer-specific virus tested in patients with advanced, metastatic disease

Oct. 13, 2000

STI-571 enhances potency of antileukemic therapies against Bcr-Abl-expressing cells

Oct. 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...